Keklik, M. Et Al. 2023. Safety and efficacy of mesenchymal stromal cell therapy for multi-drug-resistant acute and late-acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation. ANNALS OF HEMATOLOGY , vol.102, no.6 , 1537-1547.

Keklik, M., Deveci, B., Celik, S., Deniz, K., Gonen, Z. B., Zararsiz, G., ... Saba, R.(2023). Safety and efficacy of mesenchymal stromal cell therapy for multi-drug-resistant acute and late-acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation. ANNALS OF HEMATOLOGY , vol.102, no.6, 1537-1547.

Keklik, MUZAFFER Et Al. "Safety and efficacy of mesenchymal stromal cell therapy for multi-drug-resistant acute and late-acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation," ANNALS OF HEMATOLOGY , vol.102, no.6, 1537-1547, 2023

Keklik, MUZAFFER Et Al. "Safety and efficacy of mesenchymal stromal cell therapy for multi-drug-resistant acute and late-acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation." ANNALS OF HEMATOLOGY , vol.102, no.6, pp.1537-1547, 2023

Keklik, M. Et Al. (2023) . "Safety and efficacy of mesenchymal stromal cell therapy for multi-drug-resistant acute and late-acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation." ANNALS OF HEMATOLOGY , vol.102, no.6, pp.1537-1547.

@article{article, author={MUZAFFER KEKLİK Et Al. }, title={Safety and efficacy of mesenchymal stromal cell therapy for multi-drug-resistant acute and late-acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation}, journal={ANNALS OF HEMATOLOGY}, year=2023, pages={1537-1547} }